Selenoproteins and their role in oxidative stress and inflammation

Current Chemical Biology

Volumn 7, Issue 1, 2013, Pages 65-73

  Gandhi, Ujjawal H ^a   Nagaraja, Tejo P ^b   Prabhu, K Sandeep ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b THAPAR UNIVERSITY   (India)

Author keywords

Eicosanoid; Inflammation; Macrophage; Oxidative stress; Selenium; Selenoprotein

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; GLUTATHIONE PEROXIDASE; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SELENIUM; SELENIUM DERIVATIVE; SELENOLO[2,3 B]QUINOLINE; SELENOLO[2,3 C]PYRIDAZINE; SELENOLO[2,3 IB]PYRIDINE; SELENOPROTEIN; SELENOPROTEIN P; SELENOPROTEIN W; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; GLUTATHIONE METABOLISM; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LEUKOCYTE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SELENIUM DEFICIENCY; SEPTIC SHOCK; SEQUENCE HOMOLOGY; SUPPLEMENTATION;

ANIMALIA;

EID: 84878644126     PISSN: 22127968     EISSN: 18723136     Source Type: Journal    
DOI: 10.2174/2212796811307010007     Document Type: Article

References (108)

1. Forstrom JW, Zakowski JJ, Tappel AL. Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine. Biochemistry 1978; 17: 2639-44.
2. Chambers I, Frampton J, Goldfarb P, et al. The structure of the mouse glutathione peroxidase gene: the selenocysteine in the active site is encoded by the 'termination' codon, TGA. EMBO J 1986; 5: 1221-7.
3. Berry MJ, Banu L, Harney JW, Larsen PR. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J 1993; 12: 3315-22.
4. Kryukov GV, Kryukov VM, Gladyshev VN. New mammalian selenocysteine-containing proteins identified with an algorithm that searches for selenocysteine insertion sequence elements. J Biol Chem 1999; 274: 33888-97.
5. Kryukov GV, Castellano S, Novoselov SV, et al. Characterization of mammalian selenoproteomes. Science 2003; 300: 1439-43.
6. Hatfield DL, Gladyshev VN. How selenium has altered our understanding of the genetic code. Mol Cell Biol 2002; 22: 3565-76.
7. Bellinger FP, Raman AV, Reeves MA, Berry MJ. Regulation and function of selenoproteins in human disease. Biochem J 2009; 422: 11-22.
8. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci 2000; 57: 1825-35.
9. Beckett GJ, Arthur JR. Selenium and endocrine systems. J Endocrinol 2005; 184: 455-65.
10. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38-89.
11. Olivieri O, Girelli D, Azzini M, et al. Low selenium status in the elderly influences thyroid hormones. Clin Sci (Lond) 1995; 89: 637-42.
12. Kohrle J, Gartner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23: 815-27.
13. Vendeland SC, Beilstein MA, Chen CL, et al. Purification and properties of selenoprotein W from rat muscle. J Biol Chem 1993; 268: 17103-7.
14. Loflin J, Lopez N, Whanger PD, Kioussi C. Selenoprotein W during development and oxidative stress. J Inorg Biochem 2006; 100: 1679-84.
15. Musiani F, Ciurli S, Dikiy A. Interaction of selenoprotein W with 14-3-3 proteins: a computational approach. J Proteome Res 2011; 10: 968-76.
16. Panee J, Stoytcheva ZR, Liu W, Berry MJ. Selenoprotein H is a redox-sensing high mobility group family DNA-binding protein that up-regulates genes involved in glutathione synthesis and phase II detoxification. J Biol Chem 2007; 282: 23759-65.
17. Lu C, Qiu F, Zhou H, et al. Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytes. FEBS Lett 2006; 580: 5189-97.
18. Kim HY, Gladyshev VN. Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J 2007; 407: 321-9.
19. Gao Y, Feng HC, Walder K, et al. Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress - SelS is a novel glucose-regulated protein. FEBS Lett 2004; 563: 185-90.
20. Curran JE, Jowett JB, Elliott KS, et al. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 2005; 37: 1234-41.
21. Petit N, Lescure A, Rederstorff M, et al. Selenoprotein N: an endoplasmic reticulum glycoprotein with an early developmental expression pattern. Hum Mol Genet 2003; 12: 1045-53.
22. Horibata Y, Hirabayashi Y. Identification and characterization of human ethanolaminephosphotransferase1. J Lipid Res 2007; 48: 503-8.
23. Hoffmann PR, Hoge SC, Li PA, et al. The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply. Nucleic Acids Res 2007; 35: 3963-73.
24. Kasaikina MV, Fomenko DE, Labunskyy VM, et al. Roles of the 15-kDa selenoprotein (Sep15) in redox homeostasis and cataract development revealed by the analysis of Sep 15 knockout mice. J Biol Chem 2011; 286: 33203-12.
25. Ferguson AD, Labunskyy VM, Fomenko DE, et al. NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family. J Biol Chem 2006; 281: 3536-43.
26. Xu XM, Carlson BA, Irons R, et al. Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem J 2007; 404: 115-20.
27. Bosl MR, Takaku K, Oshima M, Nishimura S, Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci U S A 1997; 94: 5531-4.
28. Sengupta A, Carlson BA, Weaver JA, et al. A functional link between housekeeping selenoproteins and phase II enzymes. Biochem J 2008; 413: 151-61.
29. Neve J. Selenium as a 'nutraceutical': how to conciliate physiological and supra-nutritional effects for an essential trace element. Curr Opin Clin Nutr Metab Care 2002; 5: 659-63.
30. Kim YS, Milner J. Molecular targets for selenium in cancer prevention. Nutr Cancer 2001; 40: 50-4.
31. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res 2001; 475: 123-39.
32. Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-41.
33. McKenzie RC, Rafferty TS, Beckett GJ. Selenium: an essential element for immune function. Immunol Today 1998; 19: 342-5.
34. Hinsenkamp M. Kashin-Beck disease. Int Orthop 2001; 25: 133.
35. Gartner R, Gasnier BC. Selenium in the treatment of autoimmune thyroiditis. Biofactors 2003; 19: 165-70.
36. Turker O, Karapolat I. Selenium treatment in autoimmune thyroiditis. Thyroid 2006; 16: 1326.
37. Forceville X, Aouizerate P, Guizard M. [Septic shock and selenium administration]. Therapie 2001; 56: 653-61.
38. Gartner R, Angstwurm M. [Significance of selenium in intensive care medicine. Clinical studies of patients with SIRS/sepsis syndrome]. Med Klin (Munich) 1999; 94 Suppl 3: 54-7.
39. Shaheen SO, Newson RB, Rayman MP, et al. Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma. Thorax 2007; 62: 483-90.
40. Hoffmann PR, Jourdan-Le Saux C, Hoffmann FW, et al. A role for dietary selenium and selenoproteins in allergic airway inflammation. J Immunol 2007; 179: 3258-67.
41. Knekt P, Heliovaara M, Aho K, et al. Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology 2000; 11: 402-5.
42. Kuklinski B, Buchner M, Schweder R, Nagel R. [Acute pancreatitis--a free radical disease. Decrease in fatality with sodium selenite (Na2SeO3) therapy]. Z Gesamte Inn Med 1991; 46: 145-9.
43. McCloy R. Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy. Digestion 1998; 59 Suppl 4: 36-48.
44. Tanguy S, Boucher F, Besse S, et al. Trace elements and cardioprotection: increasing endogenous glutathione peroxidase activity by oral selenium supplementation in rats limits reperfusioninduced arrhythmias. J Trace Elem Med Biol 1998; 12: 28-38.
45. Forceville X. Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, doubleblind, multi-center phase II study--selenium and sepsis. J Trace Elem Med Biol 2007; 21 Suppl 1: 62-5.
46. Sakr Y, Reinhart K, Bloos F, et al. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth 2007; 98: 775-84.
47. Jun EJ, Ye JS, Hwang IS, Kim YK, Lee H. Selenium deficiency contributes to the chronic myocarditis in coxsackievirus-infected mice. Acta Virol 2011; 55: 23-9.
48. Beck MA, Kolbeck PC, Rohr LH, et al. Benign human enterovirus becomes virulent in selenium-deficient mice. J Med Virol 1994; 43: 166-70.
49. Dworkin BM, Rosenthal WS, Wormser GP, et al. Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex. Biol Trace Elem Res 1988; 15: 167-77.
50. Look MP, Rockstroh JK, Rao GS, et al. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 1997; 56: 31-41.
51. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 370-4.
52. Broome CS, McArdle F, Kyle JA, et al. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr 2004; 80: 154-62.
53. Bergamini CM, Gambetti S, Dondi A, Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004; 10: 1611-26.
54. Reeves MA, Hoffmann PR. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 2009; 66: 2457-78.
55. Dickinson DA, Forman HJ. Cellular glutathione and thiols metabolism. Biochem Pharmacol 2002; 64: 1019-26.
56. Chu FF, Doroshow JH, Esworthy RS. Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI. J Biol Chem 1993; 268: 2571-6.
57. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007; 9: 775-806.
58. Koyama H, Omura K, Ejima A, et al. Separation of seleniumcontaining proteins in human and mouse plasma using tandem high-performance liquid chromatography columns coupled with inductively coupled plasma-mass spectrometry. Anal Biochem 1999; 267: 84-91.
59. Kenet G, Freedman J, Shenkman B, et al. Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler Thromb Vasc Biol 1999; 19: 2017-23.
60. Conrad M, Schneider M, Seiler A, Bornkamm GW. Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals. Biol Chem 2007; 388: 1019-25.
61. Seiler A, Schneider M, Forster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 2008; 8: 237-48.
62. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000; 346 Pt 1: 1-8.
63. Holmgren A. Thioredoxin. Annu Rev Biochem 1985; 54: 237-71.
64. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005; 38: 1543-52.
65. Lundstrom J, Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J Biol Chem 1990; 265: 9114-20.
66. Andersson M, Holmgren A, Spyrou G. NK-lysin, a disulfidecontaining effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J Biol Chem 1996; 271: 10116-20.
67. Bjornstedt M, Kumar S, Holmgren A. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J Biol Chem 1992; 267: 8030-4.
68. Zhao R, Masayasu H, Holmgren A. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc Natl Acad Sci U S A 2002; 99: 8579-84.
69. Gromer S, Gross JH. Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium. J Biol Chem 2002; 277: 9701-6.
70. Kumar S, Bjornstedt M, Holmgren A. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur J Biochem 1992; 207: 435-39.
71. Jakupoglu C, Przemeck GK, Schneider M, et al. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol Cell Biol 2005; 25: 1980-8.
72. Nalvarte I, Damdimopoulos AE, Spyrou G. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition. Free Radic Biol Med 2004; 36: 1270-8.
73. Kalantari P, Narayan V, Natarajan SK, et al. Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tatdependent transcription in human macrophages. J Biol Chem 2008; 283: 33183-90.
74. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-16.
75. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem 2004; 11: 1163-82.
76. Wang X, Martindale JL, Liu Y, Holbrook NJ. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 1998; 333 (Pt 2): 291-300.
77. Ma J, Chen T, Mandelin J, et al. Regulation of macrophage activation. Cell Mol Life Sci 2003; 60: 2334-46.
78. Osterud B, Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev 2003; 83: 1069-112.
79. Kapoor M, Kojima F, Yang L, Crofford LJ. Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 103-12.
80. Lands W, Lee R, Smith W. Factors regulating the biosynthesis of various prostaglandins. Ann N Y Acad Sci 1971; 180: 107-22.
81. Maddipati KR, Marnett LJ. Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem 1987; 262: 17398-403.
82. Eskew ML, Zarkower A, Scheuchenzuber WJ, et al. Increased thromboxane A2 synthesis by rat lung neutrophils during selenium deficiency. Prostaglandins 1993; 46: 319-29.
83. Eskew ML, Zarkower A, Scheuchenzuber WJ, et al. Effects of inadequate vitamin E and/or selenium nutrition on the release of arachidonic acid metabolites in rat alveolar macrophages. Prostaglandins 1989; 38: 79-89.
84. Liu W, Li G, Zhang X. Effects of selenium and vitamin E on arachidonic acid metabolism in experimental myocardial ischaemia. Zhonghua Yu Fang Yi Xue Za Zhi 1995; 29: 279-82.
85. Eisenmann CJ, Miller RK. The effect of selenium compounds (selenite, selenate, ebselen) on the production of thromboxane and prostacyclin by the human term placenta in vitro. Toxicol Appl Pharmacol 1995; 135: 18-24.
86. Cao YZ, Reddy CC, Sordillo LM. Altered eicosanoid biosynthesis in selenium-deficient endothelial cells. Free Radic Biol Med 2000; 28: 381-9.
87. Hill TD, White JG, Rao GH. Role of glutathione and glutathione peroxidase in human platelet arachidonic acid metabolism. Prostaglandins 1989; 38: 21-32.
88. Peretz AM, Neve JD, Famaey JP. Selenium in rheumatic diseases. Semin Arthritis Rheum 1991; 20: 305-16.
89. Prabhu KS, Zamamiri-Davis F, Stewart JB, et al. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factorkappaB in up-regulation. Biochem J 2002; 366: 203-9.
90. Zamamiri-Davis F, Lu Y, Thompson JT, et al. Nuclear factorkappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 2002; 32: 890-7.
91. Vunta H, Davis F, Palempalli UD, et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14- prostaglandin J2 in macrophages. J Biol Chem 2007; 282: 17964-73.
92. Gandhi UH, Kaushal N, Ravindra KC, et al. Selenoproteindependent upregulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR){gamma}. J Biol Chem 2011.
93. Ji JD, Kim HJ, Rho YH, et al. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. Rheumatology (Oxford) 2005; 44: 983-8.
94. Sawano H, Haneda M, Sugimoto T, et al. 15-Deoxy-Delta12,14- prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells. Kidney Int 2002; 61: 1957-67.
95. Itoh K, Mochizuki M, Ishii Y, et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy- Delta(12,14)-prostaglandin j(2). Mol Cell Biol 2004; 24: 36-45.
96. Surh YJ, Na HK, Park JM, et al. 15-Deoxy-Delta(1)(2),(1)- prostaglandin J, an electrophilic lipid mediator of antiinflammatory and pro-resolving signaling. Biochem Pharmacol 2011; 82: 1335-51.
97. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007; 447: 1116-20.
98. Nelson SM, Lei X, Prabhu KS. Selenium levels affect the IL-4- induced expression of alternative activation markers in murine macrophages. J Nutr 2011; 141: 1754-61.
99. Ahrens I, Ellwanger C, Smith BK, et al. Selenium supplementation induces metalloproteinase-dependent L-selectin shedding from monocytes. J Leukoc Biol 2008; 83: 1388-95.
100. Zhang F, Yu W, Hargrove JL, et al. Inhibition of TNF-alpha induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis 2002; 161: 381-6.
101. Jackson MI, Combs GF, Jr. Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 2008; 11: 718-26.
102. Abdel-Hafez Sh H. Selenium containing heterocycles: synthesis, anti-inflammatory, analgesic and anti-microbial activities of some new 4-cyanopyridazine-3(2H)selenone derivatives. Eur J Med Chem 2008; 43: 1971-7.
103. Abdel-Hafez Sh H. Synthesis of novel selenium-containing sulfa drugs and their antibacterial activities. Bioorg Khim 2010; 36: 403-9.
104. el-Bayoumy K, Upadhyaya P, Chae YH, et al. Chemoprevention of cancer by organoselenium compounds. J Cell Biochem Suppl 1995; 22: 92-100.
105. Desai D, Madhunapantula SV, Gowdahalli K, et al. Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4- phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer. Bioorg Med Chem Lett 2010; 20: 2038-43.
106. Krishnan K, Campbell S, Abdel-Rahman F, Whaley S, Stone WL. Cancer chemoprevention drug targets. Curr Drug Targets 2003; 4: 45-54.
107. Frank DH, Roe DJ, Chow HH, et al. Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial. Cancer Epidemiol Biomarkers Prev 2004; 13: 299-303.
108. Desai D, Kaushal N, Gandhi UH, et al. Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib. Chem Biol Interact 2010; 188: 446-56.